Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif

被引:20
作者
Brown, F
Benkirane, N
Limal, D
Halimi, H
Newman, JFE
Van Regenmortel, MHV
Briand, JP
Muller, S
机构
[1] CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France
[2] USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA
关键词
foot-and-mouth disease virus; neutralization; synthetic peptide;
D O I
10.1016/S0264-410X(99)00169-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The major immunogenic site of fool-and-mouth disease virus (FMDV) is contained in a disordered loop comprising residues 134-158 of capsid protein VP1, located on the surface of the viral particle. Peptides corresponding to this sequence generally elicit protective levels of neutralizing antibodies in guinea pigs. In some instances, however, the level of neutralizing antibodies is low although the level of antibodies against the peptide, determined by ELISA, is as high as that in the sera with high neutralizing antibody titres. In an attempt to ascertain the reason for this difference, we have synthesized on a cellulose membrane 10 overlapping decapeptides, offset by one residue, covering the segment 141-159 of VP1 of two viruses belonging to serotypes A12 and O1, and tested them with guinea pig antisera raised against peptide 141-159, VP1 and FMDV particles (SPOTscan method). With type A, some peptides which were strongly positive with highly neutralizing antisera did not include the RGD triplet located at residues 145-147. In contrast, antisera with low neutralization titres reacted only with decapeptides which included the RGD motif. Moreover, peptide 147-156 coupled to keyhole limpet haemocyanin, but not peptide 141-149 coupled to the same carrier, elicited high levels of neutralizing antibodies in guinea pigs. In the case of serotype O, highly neutralizing antisera to virus reacted in ELISA with peptides 141-150 (containing the RGD motif) and 135-144 (located upstream from the RGD motif). The results suggest that the RGD tripler is not an indispensable constituent of peptides able to elicit a neutralizing antibody response against the virus. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 28 条
[1]
THE 3-DIMENSIONAL STRUCTURE OF FOOT-AND-MOUTH-DISEASE VIRUS AT 2.9-A RESOLUTION [J].
ACHARYA, R ;
FRY, E ;
STUART, D ;
FOX, G ;
ROWLANDS, D ;
BROWN, F .
NATURE, 1989, 337 (6209) :709-716
[2]
A protective anti-peptide antibody against the immunodominant site of the A(24) Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence [J].
Barnett, PV ;
Pullen, L ;
Staple, RF ;
Lee, LJ ;
Butcher, R ;
Parkinson, D ;
Doel, TR .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :1011-1018
[3]
BAXT B, 1990, Virus Genes, V4, P73, DOI 10.1007/BF00308567
[4]
ANTIBODIES TO THE VITRONECTIN RECEPTOR (INTEGRIN ALPHA(V)BETA(3)) INHIBIT BINDING AND INFECTION OF FOOT-AND-MOUTH-DISEASE VIRUS TO CULTURED-CELLS [J].
BERINSTEIN, A ;
ROIVAINEN, M ;
HOVI, T ;
MASON, PW ;
BAXT, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2664-2666
[5]
PROTECTION AGAINST FOOT-AND-MOUTH-DISEASE BY IMMUNIZATION WITH A CHEMICALLY SYNTHESIZED PEPTIDE PREDICTED FROM THE VIRAL NUCLEOTIDE-SEQUENCE [J].
BITTLE, JL ;
HOUGHTEN, RA ;
ALEXANDER, H ;
SHINNICK, TM ;
SUTCLIFFE, JG ;
LERNER, RA ;
ROWLANDS, DJ ;
BROWN, F .
NATURE, 1982, 298 (5869) :30-33
[6]
A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies [J].
Briand, JP ;
Benkirane, N ;
Guichard, G ;
Newman, JFE ;
vanRegenmortel, MHV ;
Brown, F ;
Muller, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12545-12550
[7]
ANTIBODY RECOGNITION AND NEUTRALIZATION OF FOOT-AND-MOUTH-DISEASE VIRUS [J].
BROWN, F .
SEMINARS IN VIROLOGY, 1995, 6 (04) :243-248
[8]
THE CELL ATTACHMENT SITE ON FOOT-AND-MOUTH-DISEASE VIRUS INCLUDES THE AMINO-ACID SEQUENCE RGD (ARGININE-GLYCINE-ASPARTIC ACID) [J].
FOX, G ;
PARRY, NR ;
BARNETT, PV ;
MCGINN, B ;
ROWLANDS, DJ ;
BROWN, F .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :625-637
[9]
FRANCIS MJ, 1987, IMMUNOLOGY, V61, P1
[10]
Comparison of two different methods using overlapping synthetic peptides for localizing linear B cell epitopes in the U1 snRNP-C autoantigen [J].
Halimi, H ;
Dumortier, H ;
Briand, JP ;
Muller, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 199 (01) :77-85